Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014785
Filing Date
2023-04-26
Accepted
2023-04-26 16:05:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A dice-defa14a-2022_add_ma.htm DEFA14A 23229
2 GRAPHIC img14735362_0.jpg GRAPHIC 163897
3 GRAPHIC img14735362_1.jpg GRAPHIC 105757
  Complete submission text file 0000950170-23-014785.txt   395981
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40794 | Film No.: 23849712
SIC: 2834 Pharmaceutical Preparations